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Seth H. Goldbarg and Ron I. Clyman. Cardiovascular Research Institute, Department of
Pediatrics, University ofCalifornia, San Francisco, CA. (Sponsored by George Lister,
Department ofPediatrics, Yale University School ofMedicine).
Abstract
Exposure of the fetus to indomethacin produces constriction of the fetal ductus arteriosus
(DA) and hypoxia in the avascular muscle media of the vessel wall. Hypoxia induces cell death,
which increases the incidence of patent DA in the newborn period. We used a fetal sheep model
to determine the factors that were responsible for indomethacin-induced hypoxia at various
degrees ofDA constriction. Indomethacin produced DA constriction in all fetuses studied in
vivo. Cell death in the DA wall was directly related to the degree of indomethacin-induced DA
constriction and was present at both moderate (pressure gradient across DA <16 mmHg) and
marked (>16 mmHg) degrees of constriction. Indomethacin did not alter oxygen consumption in
DA rings studied in vitro, indicating that oxygen demand in the constricting tissue is not
significantly increased by indomethacin. Both moderate and marked degrees ofDA constriction
reduced vasa vasorum flow to the ductus (moderate
=
69±25%; marked = 30+16% of pre-
indomethacin exposure values) and increased the thickness of the ductus wall. In contrast, DA
luminal blood flow was not affected by moderate degrees of constriction and was reduced only
after marked constriction. Our findings suggest that changes in vasa vasorum blood flow and
muscle media thickness are the primary contributors to hypoxia-induced cell death at moderate
degrees of indomethacin-induced constriction. Diminished luminal blood flow only appears to
contribute to the induction of cell death following the development ofmarked degrees of
constriction. These findings help to explain why in utero exposure to indomethacin in late
gestation fetuses, which depend on vasa vasorum to supply Oz to the DA muscle media, leads to
hypoxia-induced remodeling and and increased incidence of postnatal patent DA.
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The ductus arteriosus (DA) is a fetal blood vessel that connects the pulmonary
artery to the aorta. In utero, it provides a shunt from the right side of the heart to the
aorta, allowing blood to bypass the high resistance pulmonary circulation. After birth, it
is essential for the ductus to constrict so that the systemic and pulmonary circulations are
separated.
The ductus arteriosus normally closes within 24 hours of birth in the full-term
newborn. Postnatal constriction results in an initial functional closure of the DA.
Functional closure causes a decrease in DA luminal blood flow and leads to a decrease in
the diffusion of blood from the lumen into the muscle media (1). DA constriction may
also cause a decrease in blood flow through the vasa vasorum, small adventitial vessels
that provide an important blood supply to the DA muscle media in the full-term fetus.
Decreased vasa vasorum blood flow may occur through physical occlusion as the DA
muscle media constricts, or by independent constriction via the action of locally produced
vasoconstrictive substances. The loss of luminal and vasa vasorum blood supply leads to
a decreased P02, one that becomes insufficient to fulfill the oxygen needs of the vessel
wall. The resultant tissue hypoxia is associated with the local production of hypoxia-
inducible growth factors and cell death in the muscle media (2) (see diagram 1). Hypoxia
appears to be a necessary step in initiating the anatomic remodeling that leads to
permanent closure (3, 4).
Although the sequence of events leading to development of tissue hypoxia in the
constricting ductus is not known, some of the cellular and biochemical pathways leading
from tissue hypoxia to permanent DA closure in the newborn have been examined and
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deserve a brief review. Anatomic remodeling in the full-term DA occurs through
complex changes in expression of hypoxia-inducible growth factors, production of
extracellular matrix components, and migration of cells into the subendothelium.
Increased expression of growth factors including VEGF and TGF-6 are detectable in the
closing DA. VEGF is an hypoxia-inducible growth factor that is present only in areas of
lowest oxygen tension in the closing ductus (4, 5, 6). TGF-B, which is upregulated in the
outer media and adventitia of the ductus within hours of delivery, may help to sustain
contracture of the DA by increasing smooth muscle cell adhesion to the extracellular
matrix (6). Endothelial cells migrate away from the internal elastic lamina as the
subendothelium begins to widen. Accumulation of glycosaminoglycans and migration of
smooth muscle cells causes intimal thickening in the subendothelium (7). Changes in the
extracellular matrix occur as the subendothelium expands; laminin and type I collagen are
no longer expressed while production of type III collagen is upregulated (8). Endothelial
cells and smooth muscle cells express an increased range of integrins, some ofwhich are
essential for the migration of smooth muscle cells into the subendothelial region (9). The
process of neointimal formation resulting from these changes is essential for permanent
closure of the DA.
Oxygen reaches the muscle media of the DA through its lumen and its vasa
vasorum. Oxygen requirements of the arterial wall can surpass supply when oxygen
consumption is increased or oxygen delivery is decreased. Decreased delivery can result
from either a decrease in luminal or vasa vasorum blood flow or an increase in the region
of the DA muscle media that lacks vasa vasorum (see diagram 2). This area, termed the
avascular zone, is defined as the region of the arterial media adjacent to the lumen into
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which vasa vasorum do not penetrate. Large arteries appear to have an avascular zone of
constant thickness (0.47 ± 0.6 mm) (10, 11). The depth of penetration of the vasa
vasorum into the media increases with the thickness of the arterial wall such that, under
normal conditions, the avascular zone does not exceed this maximal thickness.
Oxygen tension in the walls of large arteries varies continuously, decreasing from
the luminal side to the avascular media and then increasing towards the outer muscle
media and adventitia (12). The diffusion distance to the inner (avascular) media is
greater than that to either the luminal media or adventitial media (13). Under normal
conditions, tissue oxygenation in the arterial wall reaches its lowest point at the center of
the avascular zone. This region of lowest oxygen tension, which depends on nutrient
supply from both the lumen and vasa vasorum, may be especially susceptible to
alterations in blood flow. Several studies have illustrated the dependence of the avascular
zone on the oxygen provided by vasa vasorum flow. Within a week of completely
occluding the vasa vasorum in the aorta, intimal thickening and loss ofmuscle media
cells can be seen (14). Ligation of the intercostal arteries, which supply the vasa vasorum
of the thoracic aorta, leads to medial necrosis, indicating that vasa vasorum are critical for
nutrient supply to the avascular arterial wall (11).
In contrast to the full-term newborn, the preterm DA frequently fails to achieve
permanent closure (15). In the human fetus, the ductus does not develop vasa vasorum
until the 28th week of gestation (16). Luminal blood flow is sufficient to meet the
oxygen demands of the thin-walled ductus before the 28th week. Even with functional
ductus constriction induced by indomethacin, the premature ductus, which lacks
dependence on vasa vasorum blood flow, frequently fails to remodel and does not
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permanently close. Of infants <27 weeks gestation who received prophylactic
indomethacin within 15 hours after birth, 21% failed to permanently close their ductus
and required surgical ligation (15). After 3 doses of indomethacin within 36 hours of
birth, 23% of immature infants (gestational age 23-33 weeks) had residual luminal flow
on echocardiogram, which was associated with a higher rate of clinical reopening
compared to infants with a closed ductus diagnosed by echocardiagram (1). The
development of dependence on vasa vasorum for oxygen supply appears to be critical for
achieving permanent closure.
Like preterm newborns, fetuses that have been exposed to indomethacin in utero
often fail to achieve permanent ductus closure in the newborn period (17, 18, 19). In
utero, the fetal ductus remains patent primarily as a result of prostanoids, which are
produced locally in the tissue and circulate in high concentrations. Indomethacin, a
frequently used tocolytic agent, blocks prostaglandin production. Its primary clinical use
is inhibiting the synthesis ofmaternal prostaglandins that are associated with uterine
irritability and premature labor. However, indomethacin crosses the placenta and inhibits
prostaglandin production in the fetal ductus. This inhibition induces contraction in the
fetal DA, which is associated with tissue hypoxia of the DA wall and loss of smooth
muscle cells from the muscle media (2, 20, 21) (see diagram 3). The initial
indomethacin-induced constriction often fails to completely occlude the lumen and does
not generate the levels of tissue hypoxia that are required to induce the anatomic
remodeling necessary for closure (4). However, the tissue hypoxia, cell loss, and partial
remodeling that occurs following indomethacin-induced constriction impairs the future
ability of the DA to constrict and results in an increased risk of postnatal patent ductus
9
arteriosus (2). Premature infants who have been exposed to indomethacin in utero have
an increased incidence of patent DA after birth (17, 18, 19).
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Statement of Purpose
The relative effects of changes in oxygen supply and demand on tissue hypoxia in
the constricting ductus are unknown. Indomethacin may have a direct effect on oxygen
consumption in DA tissue. On the one hand, indomethacin induces muscular
constriction, which would be expected to increase the metabolic oxygen demands of the
tissue. On the other, prostaglandin production utilizes oxygen as a substrate, and an
indomethacin-induced inhibition of prostaglandin production would be expected to
decrease oxygen utilization. The experiments in which we measured in vitro oxygen
consumption in the constricting ductus were designed to test whether metabolic oxygen
demand changed during indomethacin-induced ductus constriction.
Oxygen supply may also be affected by constriction of the near-term DA.
Decreased luminal flow, decreased vasa vasorum flow, and increased thickness of the
avascular zone may contribute to tissue hypoxia by varying degrees depending on the
degree of constriction. The studies examining ductus flow during indomethacin-induced
constriction were designed to quantify the relationship between luminal blood flow and
the degree ofDA constriction, as measured by the pressure gradient across the ductus.
We made use ofmicrosphere experiments to understand how vasa vasorum blood flow
was affected by varying degrees of indomethacin-induced ductus constriction. We also
set up an experiment that compared the thickness of the DA muscle media with the
pressure gradient that developed across the DA to study the association between
avascular zone thickness and degree ofDA constriction.
We hypothesized that indomethacin-induced constriction of the near-term fetal
DA causes tissue hypoxia primarily by compromising vasa vasorum blood flow. Clinical
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evidence has shown that infants <28 weeks gestation are less likely to be affected by in
utero indomethacin exposure than infants >28 weeks, the age at which the DA develops a
dependence on vasa vasorum blood flow (18). Initial constriction of the DA causes an
increase in the thickness of the avascular zone via circumferential and longitudinal
muscular constriction, which could cause a physical occlusion of the vasa vasorum
running through the muscle media (22). Partial indomethacin-induced constriction of the
fetal DA may decrease luminal blood flow only nominally (2). We hypothesized that
greater degrees ofDA constriction would cause a relative increase in the thickness of the
avascular zone in the DA wall. We suspected that the factors contributing to tissue




Near-term fetal sheep were used to measure DA luminal and vasa vasorum blood
flow during indomethacin-induced constriction. To measure luminal flow, we placed a
Doppler flow probe around the fetal DA (experiments performed by R. Clyman).
Microspheres were used to examine vasa vasorum blood flow, which required injection
of spheres into the superior vena cava (SVC) and inferior vena cava (IVC), as well as
blood sampling from the ascending and descending aorta following injection (see below).
A pulmonary artery (PA) catheter was placed to measure pulmonary artery pressure so
that a pressure gradient across the ductus could be determined.
All studies were approved by the Committee on Animal Research at the
University ofCalifornia, San Francisco.
Surgical Approach
Pregnant mixed Western breed sheep of 131-137 days gestation were operated
under intravenous (0.001 mg/kg/min diazepam and 0.24 mg/kg/min ketamine
hydrochloride) anesthesia. A sterile field was prepared over the anterior abdomen and a
midline incision made under local (2% lidocaine hydrochloride) anesthesia. Fetal
anesthesia consisted of local injection of 2% lidocaine hydrochloride and intramuscular
ketamine hydrochloride (20 mg/kg). The fetus was exposed via a uterine incision. Both
fetal hindlimbs were exposed and polyvinyl catheters inserted into the pedal artery and
vein on each limb and advanced to the descending aorta and inferior vena cava,
respectively. The fetal forelimb was mobilized and the pedal artery and vein catheterized
to access the ascending aorta and superior vena cava, respectively. The internal thoracic
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artery was reached through a left lateral thoracotomy in the fourth intercostal space. The
pericardium was incised along the main pulmonary trunk and a polyvinyl catheter
inserted into the pulmonary artery (see diagram 4). In 7 fetuses, the DA was isolated and
a 4-6 mm Doppler flow transducer (Transonics Systems, Ithaca, NY) was placed around
the DA. In 7 fetuses, no transducer was placed. The thoracotomy was closed. A
polyvinyl catheter was placed in the amniotic cavity. Intrauterine warm saline and
antibiotics (2 x 106 U penicillin G procaine and 200 mg gentamicin sulfate) were added
before the uterine incision was closed. The catheters were flushed with heparin sodium,
plugged, exteriorized, and placed in a pouch along the ewe's flank. The ewe was
returned to the cage after recovery from anesthesia.
Arterial pressures were measured using with pressure transducers on the
pulmonary and aortic catheters, and hemodynamic variables were recorded on a
multichannel electrostatic recorder (Gould Electronics, Pleasanton, CA). Electrical
integration was used to obtain mean pressures. Hemoglobin was measured on an OSM 2
Hemoxymeter (Radiometer Copenhagen, Denmark). Lactate was measured with a 1 500
Sport Lactate Analyzer (YSI, Yellow Springs, OH). Systemic arterial blood gases and
pH were measured on an ABL 5 Blood Gas Analyzer (Radiometer Copenhagen,
Denmark).
Luminal Flow
The day following surgery, the chronically catheterized group of fetuses with a
Doppler flow transducer (group 1, n=7) were given indomethacin (0.2 mg/kg/h given
estimated fetal weight) over 4 h. This indomethacin infusion produces stable fetal plasma
concentrations of 0.65 ± 0.24 |ig/ml plasma (2). DA constriction was assessed by
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continuous measurement of the pressure gradient between the ascending aorta and
pulmonary artery. With a patent DA, blood flows readily between the ascending aorta
and pulmonary artery. With DA constriction, the high PA pressure resulting from the
high resistance fetal pulmonary circulation can no longer be unloaded through the
narrowed DA, and a pressure gradient develops across the ductus. Moderate constriction
was defined as a pressure gradient (APress[DA]) < 16 mmHg; marked constriction was
defined as (APress[DA]) > 20 mmHg.
Vasa Vasorum Flow
Flow to vasa vasorum has been measured using the microsphere technique.
Rudolph and Heymann first used radioactive microspheres to measure fetal blood flow to
placenta and organs in 1967 (23). They provided evidence of several critical
characteristics ofmicrospheres: the distribution of spheres is proportional to blood flow;
recirculation of spheres is not significant; and injection of spheres does not alter
hemodynamics. Calculations using microspheres also depend on two assumptions: the
microspheres are completely mixed with blood near the site of injection such that
streaming does not occur; and withdrawals occur during first pass circulation through the
bloodstream (11, (23). The first microsphere experiments with vasa vasorum determined
that small (15jrm) microspheres could be used to accurately assess vasa vasorum flow
because they do not undergo shunting through arteriovenous anastamoses (24).
With this background, we set up a microsphere experiment to measure vasa
vasorum blood flow in the second group of chronically catheterized fetuses. Blood flow
to the vasa vasorum of the DA is derived from the ascending and descending aorta but
not from the pulmonary artery (Clyman, pers. comm.). Blood flows from the SVC and
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IVC into the right atrium and ventricle. In the fetus, blood supplying the vasa vasorum
then flows through either the pulmonary artery and the DA to the aortic isthmus, or
through the foramen ovale to the left ventricle and ascending aorta. We used
simultaneous microsphere injections of differing fluorescence in the SVC and IVC
because the blood from the IVC streams preferentially through the foramen ovale, and
may contribute differentially to vasa vasorum blood supply.
The vasa vasorum flow group of chronically catheterized fetuses (group 2, n=7)
received an intravenous infusion of indomethacin (0.2 mg/kg/h) the day after surgery;
infusion rate was titrated to achieve significant ductal constriction without compromising
the fetus (5-10 ml/min). DA constriction was assessed at 30 minute intervals.
Microsphere measurements were made before the indomethacin infusion began and
during the first 6 hr of the infusion (between 2 and 6 hr). Injections consisted of two sets
of 2-4 million microspheres (approximately 3xl06, 15urn; Interactive Medical
Technologies Ltd., Irvine, CA) of differing fluorescence which were simultaneously
released into the SVC and IVC catheters over 10s and followed by a saline flush. Exact
time of injection was based on the magnitude of the pressure gradient across the DA.
Reference blood samples were withdrawn from ascending and descending aorta catheters
at a constant rate (4ml/min) over the following two minutes using an automated
withdrawal system (Harvard Apparatus, South Natick, MA) (see diagram 4). Blood
withdrawals were weighed. Oxygen saturation, hemoglobin, blood pH, Pco2, P02, and
lactate were monitored at 30 minute intervals. Arterial oxygen content (ml 02/ml blood)
was determined as the product of Hb concentration, oxygen saturation, and an oxygen
binding capacity of 1.34 ml 02/g Hb. Vasa vasorum oxygen delivery (ml 02/min/gm
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tissue) was calculated as the product of arterial oxygen content and vasa vasorum blood
flow (ml blood/min/gm tissue).
Vasa Vasorum Blood Flow Determination
The vessels and blood samples were weighed, digested in alkali, and the released
fluorescent microspheres were quantified by flow cytometry (25). Process control
microspheres were added to each tissue or blood sample to determine the number of
microspheres lost during tissue processing. Vasa vasorum blood flow was calculated
from the number ofmicrospheres in the vessel, divided by the number ofmicrospheres in
the appropriate reference arterial blood sample(s), and multiplied by the reference blood
flow(s).
Systemic arterial blood gas measurements were taken every 30 minutes.
Hemodynamic variables (mean systemic and pulmonary pressures) were continuously
recorded throughout the study period. THAM was given to decrease acidosis as
appropriate. After the third microsphere injection, the lamb was given a lethal dose of
pentobarbital solution. The uterine incision was reopened and the fetus weighed. The
DA and portions of the ascending and descending aorta were removed from the fetus.
The adventitia was carefully stripped from the arterial wall.
Cell Death
Indomethacin infusion in the DA would be expected to produce a variable degree
of cell death depending on the severity of constriction and resultant tissue hypoxia that it
produced. Tissue hypoxia of the muscle wall is necessary for successful closure of the
ductus. Previous work has shown that tissue hypoxia is directly associated with cell loss.
The EF5 technique detects regions of hypoxia using nitroimidazoles that bind to cysteine
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residues on intracellular proteins after they have been reduced by hypoxia-dependent
enzymes (26). It can be used to make a quantitative estimate of oxygen concentration
within a tissue using a stain specific for EF5 tissue adducts. Experiments in the baboon
ductus have shown that areas of intense EF5 staining in the hypoxic zone also contained
large numbers of cells with evidence of nuclear fragmentation and cell death, as assayed
by the TUNEL technique. Regions with less intense EF5 binding contained no TUNEL-
positive cells. This previous work indicates that a significant association exists between
hypoxia and cell death in the ductus, and allows us to use cell death as an indicator of
tissue hypoxia (4).
With the presumption that areas of cell death in the constricting DA wall
correspond to regions of hypoxia, we attempted to determine how the degree ofDA
constriction affects the magnitude of cell death. In a third group of 17 fetuses,
indomethacin or vehicle (50mM Tris-HCl, lOml/h) was infused onto the fetus for 24 h to
determine the incidence of cell death in the DA. At the end of the infusion, the fetus was
anesthetized with ketamine HC1 and the DA was collected. The DA was dissected in
buffered salt solution at 4°C, embedded in Tissuetek (Miles, Inc., Elkhart, IN) and frozen
in liquid nitrogen.
We used the terminal deoxynucleotidyl transferase nick-end labeling (TUNEL)
technique to detect cells in the early stages ofDNA fragmentation and cell death in the
indomethacin and vehicle infused fetuses (4). This technique identifies cells undergoing
necrosis (27) as well as apoptosis (28). DNA breaks were detected with the Apoptag
Peroxidase detection system (Intergen, Purchase, NY). There was no nonspecific binding
of reagents to nuclei when deoxynucleotidyl transferase was omitted from the assay (data
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not shown). The number ofTUNEL-positive nuclei per 100 nuclei was scored in the
middle of the muscle media.
To detect endothelial cells, we incubated frozen sections with a mouse
monoclonal antibody against endothelial cell nitric oxide synthase (eNOS: Clone 3,
Transduction Lab, Lexington, KY) as previously reported (2, (4). Histologic
measurements ofwere made at the level ofminimal luminal area, which was determined
from serial sections made through the tissue. Vasa vasorum penetrate the outer muscle
media of the DA. The muscle media of all arteries has an avascular zone, adjacent to the
lumen, which lacks vasa vasorum (10). We defined the avascular zone of the DA as the
region of the DA wall between the endothelial cells lining the DA lumen and the leading
edge of the vasa vasorum. Tissue dimensions and zone thickness were determined by
averaging measurements made from 8 predetermined regions of the section, using a
Template and NIH Image software.
In Vitro Oxygen Consumption of DA Rings
Indomethacin may change oxygen consumption in DA tissue independent of
alterations in oxygen supply. We designed an apparatus that would allow for the
simultaneous determination ofO2 consumption rate and active isometric tension system
in DA rings during indomethacin-induced constriction. Fetal lambs were delivered by
Cesarean section and anesthetized with ketamine HC1 before rapid exsanguination. The
ductus was divided into rings (37±7 mg wet weight, n=6) and mounted in a 37°C, water-
jacketed glass chamber equipped with an 02 electrode (see Hellstrand P, Acta Physiol.
Scand. 1977: 100: 91) at an optimal length for tension development (7.0±0.6 mm) (29).
A conically ground, 4 cm tall plastic plug sealed the chamber and contained a small
19
channel through which a freely moveable stainless steel hook connected the ductus ring
to an isometric force transducer. The ductus ring was stretched between the moveable
hook and a fixed hook within the chamber. The long diffusion path through the small
bore hole effectively prevented the leakage of O2 into or out of the chamber (30, (31).
Sterile buffer solution (in mM: NaCl 120, KC1 4, glucose 10, MgCl2 1.2, KH2P04 1,
CaCh 2.6, HEPES 25, pH 7.45 that had been pregassed with 21% O2) passed through a
0.22|n filter before perfusing the chamber (1.2ml volume) at 0.5 ml/min. A Teflon coated
magnetic stirrer ensured adequate mixing.
The oxygen electrode (YSI Model 53 Biological Oxygen Monitor, Yellow
Springs, OH) was calibrated with 21% O2 saturated buffer. The solubility of O2 in buffer
solution was assumed to be 0.20 |0.mol/ml at 37°C, equilibrated with air (30). Oxygen
consumption rate was measured during a 10 min interval during which the tissue chamber
was closed. The background oxygen consumption rate of the system (without tissue) was
determined in each experiment. The mean background O2 consumption was 13.3% of the
mean measured tissue oxygen consumption rate, which can be attributed primarily to the
oxygen consumption of the electrode itself.
The rings were allowed to incubate for 4 h at 37°C during which time basal
oxygen consumption rate and isometric tensions stabilized. At 4 h, indomethacin (5.6
|iM) was added and the isometric tension and oxygen consumption rate were measured
during the next hour. The difference in tensions between the measured tension and the
passive tension produced by stretching the ring at the start of the experiment was
considered to be the active tension. Tissues were blotted dry and weighed after the
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experiments. The tension developed in the rings was expressed the force per unit cross-
sectional area (g/mm2) (29).
Flow Model
Vasa vasorum flow to the muscle media of the DA is derived from the ascending
and descending aorta, but not from the pulmonary artery (data not shown). Vasa vasorum
flow (ml blood/min) to the DA (Qda) can be represented as the sum of the vasa vasorum




Similarly, the number ofmicrospheres in the DA (microspheresDA) is:
microspheresDA= RaAo QaAo + RdAo QdAo (eqn. A)
where R is the concentration ofmicrospheres (microspheres/ml/min) in the corresponding
ascending aorta or descending aorta reference samples.







where x is the proportion of flow to the DA from the descending aorta.
Substituting eqn. B and eqn. C in eqn. A and then solving for x:
x
=




To measure Qda we use 2 different sets ofmicrospheres (#1, #2) that are injected
simultaneously. Since x is the same for microsphere #1 and #2:
microspheresDM^RaAoiOjA
=
microspheresnA?- RaAo2QDA (eqn. E)
RdAolQDA RaAolQDA RjAo2QdA RaAo2QDA
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[RdAol - RaAol] [RdAo2 ; RaAo2l
RaAnl " RaAo2
[RdAol " RaAol] [RdAo2 RaAo2]
Statistics
Comparison of unpaired data was performed by the appropriate t-test or
regression analysis. When more than one comparison was made, Bonferroni 's correction
was used. Nonparametric data were compared with a Mann-Whitney test. Results are
presented as means ± SD.
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Results
We used 56 fetal sheep to determine which factors were responsible for
indomethacin-induced DA tissue hypoxia. An infusion of indomethacin was associated
with DA constriction and evidence of cell death (as demonstrated by the increased
incidence ofTUNEL-positive cells) in the middle of the DA muscle media (the region of
the avascular zone adjacent to the leading edge of the vasa vasorum) (Fig 1). By 24 hr,
an extensive region of cell loss (absent nuclei) was already apparent in the avascular zone
of four of the DA (Fig 1,2). The incidence ofTUNEL-positive cells in the DA wall was
directly related to the degree ofDA constriction (r=0.91, n=17, pO.0001) (Fig 1). Even
moderate degrees ofDA constriction (<16 mmHg gradient) were associated with an
increase in the incidence of cell death.
Although indomethacin produced a significant increase in active tension ofDA
rings, in vitro, it had no effect on tissue oxygen consumption (Fig 3).
We determined luminal blood flow using Doppler flow transducers around the
DA (n=7). Indo constricted the DA in all fetuses (pressure gradient, APress[DA] (mm
Hg): preinfusion
=
1±1, 4 h = 14±6). Indomethacin altered DA luminal blood flow;
however, this was observed only after marked degrees of constriction had been achieved.
Moderate constriction (APress[DA] <16 mmHg) did not affect DA luminal flow. Marked
constriction (>16 mmHg) reduced luminal flow to 64±28% of preinfusion levels.
Vasa vasorum flow was determined with fluorescent microspheres (n=7). In
contrast to luminal flow, vasa vasorum flow to the DA media was inversely related to the
degree ofDA constriction (r=-0.79, p<0001)(Fig 5). At moderate constriction, vasa
vasorum flow was 69±25% of preinfusion levels; at marked constriction, it fell to
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30±16%. Oxygen delivery through the vasa vasorum fell in parallel with vasa vasorum
flow (in ml 02/min/gm: preinfusion = 0.059± 0.015; moderate ductus constriction (>4 to
<16 mmHg gradient)
= 0.024± 0.014; marked constriction (>16 mmHg)
= 0.017 ± 0.005).
In contrast, vasa vasorum flow to the ascending aorta was not affected by indomethacin
(in ml/min/gm: preinfusion
= 0.027± 0.008; indomethacin = 0.022± 0.010); nor was it
affected by the degree ofDA constriction (in ml/min/gm: pressure gradient <4 mmHg
=
0.027± 0.007 versus pressure gradient >16 mmHg
= 0.024± 0.014). Individual DA
response to indomethacin varied significantly. When experimental flow values for each
animal were normalized to control flow values, the relationships to pressure gradient
were unchanged. Blood flow to the DA adventitia was not related to the pressure
gradient across the ductus.
Indomefhacin-infused fetuses had a marked increase in the thickness of their
muscle media when compared with vehicle-infused fetuses (Fig 6). The number of
concentric muscle layers throughout the DA was similar in indomethacin (46±6, n=9) and
vehicle-infused (44±3, n=8) fetuses. The difference in wall thickness was due to a
substantial increase in avascular zone thickness in the indomefhacin-infused fetuses. The
thicknesses of both the avascular zone (r=0.95, n=17, pO.Ol) and the total muscle media
(r=0.64, n=17, p<0.01) were directly related to the degree ofDA constriction; both were
increased significantly even at moderate degrees ofDA constriction (Fig 6).
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Discussion
The present study attempts to identify the factors that contribute to tissue hypoxia
in the fetal ductus undergoing indomethacin-induced constriction. As the ductus
constricts initially, resistance to blood flow through the DA increases, and the pressure
gradient between the PA and aorta increases. As the pressure gradient increases,
constriction of the muscle media of the DA may cause a decrease in blood flow through
the vasa vasorum that course into the muscle media from the adventitia. The increase in
muscle media thickness during constriction may increase the distance required for
oxygen diffusion into the avascular zone. The decrease in DA luminal blood flow that
occurs with marked degrees of initial functional closure leads to a decrease in the
diffusion of blood from the lumen into the muscle media (1). The loss of luminal and
vasa vasorum blood supply leads to a decreased P02, one that becomes insufficient to
fulfill the oxygen needs of the widened vessel wall. The tissue hypoxia that develops
seems to be a critical initiator of the anatomic remodeling that leads to permanent closure
(3,4).
The sequence of events leading from ductus constriction to permanent closure is
complex. Ductus constriction is initiated by a decrease in prostaglandin production and
sensitivity. The ductus is extremely sensitive to the vasodilating effects of prostanoids,
particularly PGE2, which appears to play a primary role in maintaining ductus patency
(32). Prostaglandins are produced primarily by the cyclooxygenase enzyme, which exists
in 2 isoforms, COX-1 and COX-2. COX-1 is found in endothelial and smooth muscle
cells of the ductus wall, while COX-2 is found exclusively in endothelium. In the fetus,
selective inhibition of the COX-1 or COX-2 enzymes independently produces
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constriction in the fetal lamb ductus (33). In contrast, the newborn ductus has a much
more attenuated response to both COX-1 and COX-2 inhibition, indicating a decrease in
expression of both of the COX enzymes soon after delivery (3). The decreased postnatal
production of PGE2 leads to a lower level of circulating vasodilator, which helps to
initiate the process of DA constriction.
In addition to a decreased production of prostaglandins by cyclooxygenase, the
full-term newborn also has a decreased vasodilator/ response to PGE2. PGE2 acts
through four receptors, EP], EP2, EP3, and EP4, each ofwhich is coupled to a distinct
second messenger system (34). The fetal ductus expresses three of the four receptors,
EP2, EP3, and EP4. In contrast, ligand binding studies and selective EP-receptor
stimulated cAMP production experiments have both shown that the newborn ductus
undergoes complete loss of EP3 and EP4 receptors, leaving only EP2 receptor
concentration unchanged (35). Both decreased prostaglandin production and altered
receptor expression decrease the vasodilatory stimuli in the newborn ductus. These
changes initate the process of newborn DA constriction and closure.
It should be noted that nitric oxide (NO) also appears to play a role in regulating
the postnatal ductus. NO regulates tone in many vascular beds. RT-PCR and
immunohistochemistry have been used to show that two of the three NO synthase (NOS)
isoforms are present in the DA, ecNOS and iNOS. The former appears to exert the
greatest effect on contractility (36). Experiments with competitive inhibitors ofNO
synthase have shown that blocking NO production in the oxygen-constricted ductus
produces a significant further constriction. In contrast, at low P02, competitive NO
synthase inhibitors had little effect (36). In the DA, NO may play an important
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regulatory role at high but not low P02. NO release appears be minimal at fetal P02, but
may be upregulated and have significant vasodilatory effects at neonatal P02s. The
constriction resulting from decreased prostaglandin production and sensitivity may lower
Po2 sufficiently to decrease nitric oxide synthesis.
Constriction of the DA leads to tissue hypoxia in the muscle media. Tissue
hypoxia may result from a decrease in DA luminal or vasa vasorum blood flow, or an
increase in the thickness of the muscle media. Previous work has shown that regions of
tissue hypoxia in the constricting DA muscle media closely correspond with areas of cell
death (4). Cell death and anatomic remodeling are required for the DA to achieve
permanent closure. As previously discussed, permanent closure occurs through changes
in expression of hypoxia-inducible growth factors, production of extracellular matrix
components, and cell migration.
Indomethacin has been shown to induce constriction of the fetal and newborn DA
in clinical studies, primarily through inhibition of PGE2 (20). This mechanism has led to
the use of indomethacin as a treatment for patent ductus arteriosus (PDA) in newborns.
However, indomethacin also leads to constriction of the fetal DA when used maternally
as a tocolytic agent. Indomethacin-induced constriction of sufficient severity leads to
hypoxia of ductus tissue and initiation of anatomic remodeling, as well as an increase in
avascular zone thickness (2).
Indomethacin induced constriction in all the study fetuses. We verified that
exposure of the fetus to indomethacin produced nuclear fragmentation and cell death in
smooth muscle cells of the DA muscle media (Fig 1,2). We have previously found that
decreased cell viability in the DA muscle media (in addition to a reduction in NO
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production) leads to a significant decline in both tissue distensibility and contractile
capacity and explains why the newborn DA remains patent and fails to close after
indomethacin exposure in utero (2). The DA that has been exposed to indomethacin in
utero may retain some constrictive capacity, but its ability to constrict sufficiently to
induce the tissue hypoxia and subsequent anatomic remodeling needed for permanent
closure is compromised. The pattern and location of cell death in the avascular zone of
the DA wall suggest that the profound muscle media hypoxia that develops during DA
constriction is responsible for this reduced response to indomethacin (2, 4). We found
that the extent of cell death is directly related to the degree ofDA constriction (Fig 1).
Cell death occurred even at moderate degrees of constriction, suggesting that tissue
hypoxia becomes significant even before the DA constricts completely.
Moderate indomethacin-induced constriction produces cellular changes associated
with tissue hypoxia, which appears to be the critical initiator of the anatomical changes
that lead to failed constriction. However, the specific mechanisms leading from
constriction to tissue hypoxia have not been clearly delineated. In the maturing fetus,
oxygen delivery to the ductus wall is tightly regulated. Vasa vasorum appear
to invade
the fetal DA only when the developing muscle media attains a certain minimal thickness,
presumably outgrowing diffusion of nutrients from
the luminal flow. Although vessel
wall thickness varies markedly between species, the thickness of the inner avascular zone
of the muscle media remains constant at 0.47 ± 0.06 mm (10, 1 1, 37, 38). The avascular
zone, which depends on flow from both the lumen and the vasa vasorum, is particularly
vulnerable to changes in oxygen demand or supply.
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We examined which contributors to oxygen supply (luminal blood flow, vasa
vasorum blood flow, and avascular zone thickness) and oxygen demand (indomethacin-
induced changes in oxygen consumption) were affected by indomethacin-induced DA
constriction. Our findings indicate that the increased incidence ofmuscle media cell
death associated with indomethacin-induced constriction was not due to an increase in
tissue oxygen consumption in vitro (Fig 3). Indomethacin had no effect on oxygen
consumption in the DA; this finding is consistent with other studies in both
noncontractile (hepatic, jejunal, gastric, and cerebral) and contractile (myocardial) tissues
(39, 40, 41, 42, 43). Indomethacin is known to cause DA constriction by inhibiting
prostaglandin production and unmasking the intrinsic tone in the ductus. While overall
oxygen consumption does not appear to change during indomethacin-induced
constriction, opposing pathways may be at work and could help to explain this finding.
An increased metabolic need for oxygen during constriction could be balanced by a
decreased requirement for oxygen as a substrate for prostaglandin synthesis. Conversely,
decreasing oxygen concentration may also have a direct influence on DA prostaglandin
production, suggesting that a more complex feedback loop may exist (44, 45). In
addition, small overall changes in oxygen consumption may not have been detectable
with the apparatus that we developed. Although indomethacin requires oxygen to
produce constriction in DA rings in vitro, it does not appear from our experiment to alter
net DA oxygen consumption independently (36). This novel finding suggests that
oxygen demand is not a driving force for tissue hypoxia in indomethacin-induced DA
constriction.
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On the other hand, indomethacin had a profound effect on the blood flow and
muscle media oxygen supply to the ductus. Indomethacin decreased both the DA luminal
and vasa vasorum blood flow, and at the same time increased the thickness of the DA
avascular zone (Fig 4,5,6).
Indomethacin induced DA constriction in all fetuses, leading to an increased
resistance to luminal flow. In the fetus, high pulmonary vascular resistance opposes the
increase in pulmonary blood flow that occurs during DA constriction in the newborn. At
moderate degrees ofDA constriction, the pressure generated by right ventricular
contraction was sufficient to overcome the increasing resistance to flow through the
contracting DA. Not until the pressure gradient across the DA exceeded 20 mmHg did
luminal flow begin to decrease in comparison to preinfusion levels. The right ventricular
pressure generated at moderate levels of constriction appears to be sufficient to preserve
DA luminal blood flow. Our experiments establish that luminal blood flow is
compromised only at marked degrees of constriction, and may not contribute to hypoxia
during moderate constriction.
Tissue compaction during constriction of the DA is responsible for the initial
increase in avascular zone thickness in the DA wall (22). We hypothesized that
indomethacin's effect on vasa vasorum blood flow was due to physical compression of
the thin walled vasa vasorum during constriction of the DA outer muscle media; the
reduction in DA vasa vasorum blood flow was directly related to the degree of DA
constriction (Fig 5). The novel finding in this experiment is that vasa vasorum blood
flow to the DA media was reduced even at moderate levels of constriction, and further
reduction occurred as DA constriction grew more severe. Physical occlusion could
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explain the decreased flow through vasa vasorum, although other factors may play a role.
The vasa vasorum are lined with smooth muscle cells and may also respond
independently to local changes in oxygen supply, glucose level, and soluble mediators of
constriction. An initial compression and reduction in blood flow could subsequently alter
local conditions that might contribute to constriction. Neurohumoral reflexes might also
contribute to the constrictive response to tissue hypoxia (46). We noted no decrease in
vasa vasorum flow in the adjacent aorta during ductus constriction, indicating that in
general vasa vasorum do not respond independently to indomethacin. However, it is
possible that, like the ductus luminal endothelium, ductus vasa vasorum may have a
unique sensitivity to prostaglandins which contributes to constriction during
indomethacin infusion. Reduced blood supply from vasa vasorum during moderate
constriction would contribute to decreased oxygen tension in the susceptible avascular
zone. Marked constriction appears to generate tissue hypoxia through both a further
decrease in vasa vasorum flow and compromised luminal blood flow.
The notion that tissue compaction physically occludes the vasa vasorum in the
muscle media is reinforced by the finding that adventitial vasa vasorum flow did not
consistently decline during DA constriction. Adventitia generally receives a relatively
higher blood flow via vasa vasorum than does the muscular media in vascular tissue. Our
data did not show a consistent relationship between ductal constriction and adventitial
flow. The vasa vasorum in the adventitia may escape the constrictive effect that
contraction of the muscular media has on medial vasa vasorum. Adventitial vasa
vasorum did not appear to constrict predictively with indomethacin, which would have
suggested that another mechanism at work. It should be noted that fetal brown fat, which
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is highly vascularized and difficult to completely remove from adventitial tissue, may
have affected the accuracy of our adventitial flow data.
In addition to its effects on blood flow to the DA, indomethacin caused a marked
increase in the thickness of the muscle media and the oxygen diffusion gradient across
the avascular zone of the DA wall (Fig 6). The increased avascular zone thickness was
due to tissue compaction (caused by circumferential and longitudinal muscle constriction)
(4, 22). Particularly intriguing from this study is that even moderate degrees ofDA
constriction produced an increase in avascular zone thickness (Fig 6). The thickness of
the avascular zone was directly related to the degree ofDA constriction. The resulting
increase in diffusional distance may decrease oxygen tension in the center of the
unperfused media; at moderate levels of constriction, avascular zone thickness was 151%
of control values. The combination of increased avascular zone thickness and decreased
blood flow through vasa vasorum at moderate levels of constriction facilitate tissue
hypoxia generation in the muscle media.
Our findings allow us to speculate on some of the previosly noted clinical effects
of indomethacin on the DA. Wall thickness in the preterm DA is less than that of the
full-term DA, and the preterm ductus may not be as dependent on vasa vasorum flow for
oxygenation. With more immature infants, permanent ductus closure becomes
increasingly difficult (15). Even with functional constriction, the preterm DA is less able
to generate the levels of tissue hypoxia required for anatomic remodeling (4). Because
the preterm ductus may not be dependent on vasa vasorum flow, moderate levels of
constriction, which our experiments have shown do not affect luminal flow, may not be
sufficient to produce the levels of hypoxia necessary for DA closure. Marked
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constriction, which begins to compromise luminal flow, may be needed for permanent
remodeling and closure. The sustained levels of tissue hypoxia required for permanent
remodeling in the preterm ductus may only be reached with the most marked levels of
constriction.
It is interesting to note that indomethacin exposure in utero is more likely to be
associated with a patent ductus arteriosus when the exposure occurs later in gestation
(18). The presence of vasa vasorum in the muscle media depends on the thickness of the
arterial wall (10, 47). In the human fetus, vasa vasorum usually enter the ductus wall
after the 28th week of gestation (16). Before 28 weeks, luminal blood flow is sufficient to
meet the oxygen demands of the thin-walled ductus. Previous reports have shown that
infants >28 weeks gestation are much more likely to be affected by in utero indomethacin
exposure than infants <28 weeks gestation (18). When late gestation fetuses are exposed
to indomethacin in utero, ischemic changes in the muscle wall occur even before there
are any changes in ductus luminal flow (2) (Fig. 1). An increase in avascular zone
thickness and a decrease in vasa vasorum flow appear to be responsible for the tissue
hypoxia and cell death that occur in the late gestation ductus. These novel findings help
to explain why infants <28 weeks gestation (who do not depend on vasa vasorum flow to
provide nutrition to their ductus wall) are much less likely to be affected by indomethacin
exposure in utero, while fetuses >28
weeks gestation who are exposed to indomethacin
have a higher incidence of postnatal patent ductus arteriosus.
Although newborns >28 weeks gestation who have received indomethacin in
utero are at greater risk than premature infants, both groups have an increased incidence
of postnatal patent ductus arteriosus. The preterm newborn may respond to both earlier
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pharmacologic intervention and an increased number of indomethacin doses with more
severe constriction, increasing the likelihood of permanent closure (15). Because the
preterm DA has not undergone cellular remodeling and hypoxic change, its constrictive
capacity would be expected to remain intact. In contrast, the newborn exposed to
indomethacin in utero after 28 weeks gestation is far more likely to have sustained
hypoxia-induced injury to the DA wall, which makes it less responsive to prostaglandin
inhibition as a newborn. Intensive treatment with indomethacin may increase closure
rates in premature infants, but other forms of treatment for PDA might be more
appropriate in patients who have received indomethacin after 28 weeks gestation.
Clinical studies would help to better define the effect of postnatal indomethacin on
different groups at risk for patent ductus arteriosus.
Further work is needed to more completely characterize the relationship between
indomethacin-induced DA constriction, tissue hypoxia, cell death, and ductus closure.
Oxygen consumption is difficult to measure in the ductus because of the multiple oxygen
utilization pathways present and the small size of the tissue. Further experiments might
use a substance that induced constriction independent of prostaglandins, since
prostaglandin production requires oxygen as a substrate. Measuring oxygen consumption
after potassium administration, which induces intense ductus constriction, might allow
for better characterization ofmetabolic vs. substrate-driven oxygen consumption (36).
More precise characterization of the hypoxic threshold for apoptosis and cell
death is currently underway. Using an in vitro tissue bath system in which the oxygen
and glucose concentration of the media can be carefully controlled, we have begun to
study TUNEL staining in both the near-term and premature fetal ductus under a variety of
conditions. Using rings ofDA from mature and immature lamb fetuses suspended in
organ culture baths, we incubated tissue for 24 h at high and low concentrations of both
O2 and glucose. Initial findings indicate that the percentage ofTUNEL stained cells
increases with either hypoxia or hypoglycemia, but that extensive cell death, as normally
occurs in the full-term newborn in vivo, was seen exclusively in rings exposed to both
hypoxic and hypoglycemic conditions. Mature and immature DA tissue response was
similar, indicating that the preterm DA is equally susceptible to cell death when hypoxia
and hypoglycemia become sufficiently severe.
Our data suggested that the DA vasa vasorum have a critical role in inducing
tissue hypoxia at moderate degrees of constriction, even in the presence of persistent
luminal blood flow. We designed an experiment to determine whether loss of vasa
vasorum flow alone is sufficient to produce tissue hypoxia and remodeling of the DA
wall. We performed a thoracotomy on 6 fetal lambs and cauterized the adventitial
surface of the main pulmonary artery, aortic isthmus, and descending aorta. The vasa
vasorum travel through the adventitia of these vessels before perfusing the DA. Initial
findings indicate a marked reduction in perfusion of cells in the regions supplied by the
cauterized vasa vasorum. There was an increase in neointimal thickness and cell death in
the affected areas of the DA wall. These findings support our contention that vasa
vasorum occlusion in the late gestation DA is sufficient to produce tissue hypoxia and
anatomic remodeling. The premature DA, which lacks vasa vasorum, would need to
completely obliterate its lumen before generating the same degree of tissue hypoxia.
This study establishes a critical role for vasa vasorum as a regulator of tissue
oxygenation in the near-term ductus undergoing indomethacin-induced constriction.
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Even moderate degrees of constriction are sufficient to decrease vasa vasorum blood flow
and increase wall thickness and oxygen diffusion distance to the avascular zone. These
findings explain why infants exposed to indomethacin in utero after 28 weeks gestation
(the time at which vasa vasorum begin to provide a vital oxygen supply to the ductus
wall) have an increased incidence of postnatal patent DA. Luminal flow, which provides
oxygenation to the DA wall prior to 28 weeks, is only reduced at the most severe levels
of indomethacin-induced constriction, and may not be as frequent a contributor to tissue
hypoxia near-term ductus. Further studies are underway to more precisely define the
hypoxic thresholds for cell death and anatomic remodeling in the DA, and to establish the
dependence of the near-term ductus on the vasa vasorum for oxygen supply.
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Figure Legends
Figure 1. Moderate and marked degrees of constriction cause an increase in TUNEL-
positive cells and cell loss in the ductus. Fetuses were infused with either vehicle
(control, n=8) or indomethacin (n
=
9). Pressure gradient across the ductus was measured
just prior to necropsy. Filled circles and squares represent the number ofTUNEL-positive
nuclei (per 500 nuclei) found in a 67 urn wide, circumferentially oriented region around
the middle of the muscle media (see Methods). In 4 indomefhacin-infused ductus
(indicated by a ring around a closed circle), an extensive region (> 20,000 urn2) of cell
loss was observed in the middle of the muscle media. One ductus no longer had evidence
ofTUNEL staining and had only an extensive region of cell loss at the time of necropsy.
Figure 2. Three contiguous regions from the middle of a single ductus showing TUNEL-
positive nuclei (brown) bordering a region of extensive cell loss. Panel (A) shows a large
area of cell loss bordered by TUNEL positive nuclei. Panel (C) shows mostly TUNEL
positive cells before the cell nuclei disappear. Hematoxylin (blue) counterstain.
Figure 3. Indomethacin increases active tension in DA rings in vitro but has no effect on
oxygen consumption (n
=
6). DA rings were incubated in buffer solution for 4 hr (control
period) prior to indomethacin exposure. See Methods for details. Arrows indicate time of
indomethacin (5.6 U.M) addition. Values
=
mean ± SD, n = 6.
*
p<0.05 versus control
(-15 min) period. p<0.05: tension at 60 min versus tension at 30 min.
Figure 4. Only marked degrees of ductus constriction decrease ductus luminal blood
flow during indomethacin infusion. Panel A) Ductus luminal blood flow and pressure
gradient across the ductus were monitored continuously during an indomethacin infusion
into 7 fetal sheep. See Methods. Open diamonds
= values prior to indomethacin infusion
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(n = 7); closed diamonds = values during indomethacin infusion. Values represent the
mean (± SD) luminal flow at each pressure gradient across the ductus; all 7 fetuses
developed pressure gradients up to 16 mm Hg during the indomethacin infusion; only 3
fetuses had pressure gradients that also went up to 24 mm Hg. Panel B) Columns
represent the mean (± SD) flows before indomethacin (preinfusion, open column) and
during the indomethacin infusion (closed columns), when the pressure gradient was either
<4 mm Hg, between 4 and 16 mm Hg, or >16 mm Hg. *p<0.05 versus preinfusion
values.
Figure 5. Both moderate and marked degrees of ductus constriction decrease ductus vasa
vasorum blood flow during indomethacin infusion. Panel A) A preinfusion microsphere
measurement of ductus vasa vasorum blood flow was performed in each of the 7 fetuses
prior to starting the indomethacin infusion. Following the preinfusion measurements, a
total of 13 measurements were performed during the indomethacin infusions in the 7
fetuses (see Methods). Pressure gradients across the ductus were measured during each
microsphere measurement. Panel B) Columns represent mean (±SD) vasa vasorum flow
prior to indomethacin (open column, n
=
7) and during the indomethacin infusion (closed
columns) when the pressure gradient was either <4 mm Hg (n
=
2), between 4 and 1 6 mm
Hg (n
=
7), or >16 mm Hg (n
=
4). *p<0.05 versus preinfusion values; p<0.05 versus
values when pressure gradient was between 4 and 16 mm Hg.
Figure 6. Both moderate and marked degrees of ductus constriction increase the
thickness of the avascular zone and total muscle media of the ductus, (see Methods for
definitions). Fetuses were infused with either vehicle control (open columns, n = 8) or
indomethacin (closed columns, n
=
9) for 24h. Pressure gradient across the ductus was
44
measured prior to necropsy. Histologic measurements obtained from indomefhacin-
infused fetuses with a moderately constricted ductus (>4 and <16 mmHg, n
=
6) and
those with a markedly constricted ductus (>16 mmHg, n
=
3) were compared with control
fetuses (<4 mmHg, n
=
8). *p<0.01, p<0.05 versus control values. #p<0.05 versus values
when pressure gradient across ductus was >4 and <16.
Diagram 1 Functional DA Constriction
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